VA SB592 | 2024 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 10 2024 - 25% progression
Action: 2024-02-08 - Continued to 2025 in Education and Health (15-Y 0-N)
Pending: Senate Education and Health Committee
Text: Latest bill text (Prefiled) [HTML]

Summary

Department of Medical Assistance Services; Preferred Drug List/Common Core Formulary; approval of a nonpreferred drug. Directs the Department of Medical Assistance Services to eliminate the requirement that a patient try and fail a drug from the Preferred Drug List/Common Core Formulary in the six months immediately prior to approval of a nonpreferred drug when such patient has previously tried the drug from the Preferred Drug List/Common Core Formulary and experienced harmful side effects.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Preferred Drug List/Common Core Formulary; approval of a nonpreferred drug.

Sponsors


Roll Calls

2024-02-08 - Senate - Senate: Continued to 2025 in Education and Health (15-Y 0-N) (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2024-02-08SenateContinued to 2025 in Education and Health (15-Y 0-N)
2024-02-05SenateAssigned Education and Health Sub: Health
2024-01-10SenateReferred to Committee on Education and Health
2024-01-10SenatePrefiled and ordered printed; offered 01/10/24 24103030D

Subjects


Virginia State Sources


Bill Comments

feedback